[go: up one dir, main page]

CA2971197A1 - Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes - Google Patents

Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes Download PDF

Info

Publication number
CA2971197A1
CA2971197A1 CA2971197A CA2971197A CA2971197A1 CA 2971197 A1 CA2971197 A1 CA 2971197A1 CA 2971197 A CA2971197 A CA 2971197A CA 2971197 A CA2971197 A CA 2971197A CA 2971197 A1 CA2971197 A1 CA 2971197A1
Authority
CA
Canada
Prior art keywords
composition
thc
cbd
skin
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2971197A
Other languages
English (en)
Inventor
Alon SINAI
Ziv TURNER
Yehuda Baruch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
One World Cannabis Ltd
Original Assignee
One World Cannabis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One World Cannabis Ltd filed Critical One World Cannabis Ltd
Priority to CA2971197A priority Critical patent/CA2971197A1/fr
Publication of CA2971197A1 publication Critical patent/CA2971197A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3482Cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2971197A 2017-06-20 2017-06-20 Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes Abandoned CA2971197A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2971197A CA2971197A1 (fr) 2017-06-20 2017-06-20 Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2971197A CA2971197A1 (fr) 2017-06-20 2017-06-20 Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes

Publications (1)

Publication Number Publication Date
CA2971197A1 true CA2971197A1 (fr) 2018-12-20

Family

ID=64755018

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2971197A Abandoned CA2971197A1 (fr) 2017-06-20 2017-06-20 Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes

Country Status (1)

Country Link
CA (1) CA2971197A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019144189A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour l'acné
WO2019144191A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour le psoriasis
WO2019144190A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour dermatite et affections cutanées inflammatoires
IT202000017137A1 (it) * 2020-07-15 2022-01-15 Linnea Sa Estratti di cannabis sativa e loro usi
CN114340604A (zh) * 2019-06-26 2022-04-12 康宝动物治疗有限公司 Cbd组合物
WO2022128390A1 (fr) 2020-12-14 2022-06-23 Symrise Ag Compositions cosmétiques et/ou pharmaceutiques contenant des cannabinoïdes
CN114901071A (zh) * 2019-11-08 2022-08-12 维拉生物科技有限公司 外周作用的含有大麻二酚(cbd)的组合物及其用于增强女性性功能或治疗女性性障碍的用途
EP4079301A2 (fr) 2021-04-19 2022-10-26 Symrise AG Compositions comprenant du cannabidiol et, éventuellement, du bisabolol
WO2023280636A1 (fr) * 2021-07-05 2023-01-12 TULICHEM GmbH Produit de soin et de protection de la peau, et de désinfection de plaies, toléré par la peau, à appliquer sur la peau

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019144191A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour le psoriasis
WO2019144190A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour dermatite et affections cutanées inflammatoires
WO2019144189A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour l'acné
US11896560B2 (en) 2018-01-24 2024-02-13 Botanix Pharmaceuticals Ltd. Cannabinoid dosing regime for dermatitis and inflammatory skin conditions
CN114340604A (zh) * 2019-06-26 2022-04-12 康宝动物治疗有限公司 Cbd组合物
CN114901071A (zh) * 2019-11-08 2022-08-12 维拉生物科技有限公司 外周作用的含有大麻二酚(cbd)的组合物及其用于增强女性性功能或治疗女性性障碍的用途
JP2023535313A (ja) * 2020-07-15 2023-08-17 リネア・ソチエタ・アノニマ アサ(Cannabis sativa)抽出物およびその使用
IT202000017137A1 (it) * 2020-07-15 2022-01-15 Linnea Sa Estratti di cannabis sativa e loro usi
WO2022013736A1 (fr) * 2020-07-15 2022-01-20 Linnea Sa Extraits de cannabis sativa et leurs utilisations
WO2022128390A1 (fr) 2020-12-14 2022-06-23 Symrise Ag Compositions cosmétiques et/ou pharmaceutiques contenant des cannabinoïdes
WO2022223099A1 (fr) 2021-04-19 2022-10-27 Symrise Ag Compositions comprenant du cannabidiol et, éventuellement, du bisabolol
EP4079301A2 (fr) 2021-04-19 2022-10-26 Symrise AG Compositions comprenant du cannabidiol et, éventuellement, du bisabolol
WO2023280636A1 (fr) * 2021-07-05 2023-01-12 TULICHEM GmbH Produit de soin et de protection de la peau, et de désinfection de plaies, toléré par la peau, à appliquer sur la peau

Similar Documents

Publication Publication Date Title
US10603301B2 (en) Cannabis-based extracts and topical formulations for use in skin disorders
CA2971197A1 (fr) Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes
Hou et al. Sea buckthorn (Hippophaë rhamnoides L.) oil improves atopic dermatitis-like skin lesions via inhibition of NF-κB and STAT1 activation
Meng et al. Psoriasis therapy by Chinese medicine and modern agents
RU2671492C2 (ru) Композиции, содержащие берберин или его аналоги для лечения кожных заболеваний, связанных с розацеа или с покраснением лица
CA2823086C (fr) Extraits vegetaux pour le traitement et la prevention d'infections
Xie et al. Eucommia ulmoides Oliv. bark aqueous extract inhibits osteoarthritis in a rat model of osteoarthritis
Wang et al. Inhibitory effect of gallic acid on CCl4-mediated liver fibrosis in mice
Wang et al. Huanglian ointment alleviates eczema by maintaining the balance of c-Jun and JunB and inhibiting AGE-RAGE-mediated pro-inflammation signaling pathway
Liu et al. Angelica Yinzi alleviates 1-chloro-2, 4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs/NF-kB signaling pathway
Wu et al. Effects of topical application of a tri-herb formula on inflammatory dry-skin condition in mice with oxazolone-induced atopic dermatitis
Wang et al. Ameliorative effects of sea buckthorn oil on DNCB induced atopic dermatitis model mice via regulation the balance of Th1/Th2
Abali et al. Efficacy of acupuncture on pain mechanisms, inflammatory responses, and wound healing in the acute phase of major burns: an experimental study on rats
Milani et al. Cariniana domestica fruit peels present topical anti-inflammatory efficacy in a mouse model of skin inflammation
Pan et al. Wu-Zi-Yan-Zong-Wan protects mouse blood-testis barrier from Tripterygium wilfordii Hook. f. multiglycoside-induced disruption by regulating proinflammatory cytokines
Yu et al. Yuhong ointment ameliorates inflammatory responses and wound healing in scalded mice
Martínez et al. Reporting a fatality during tumescent liposuction
Li et al. Arctiin Alleviates Atopic Dermatitis Against Inflammation and Pyroptosis Through Suppressing TLR4/MyD88/NF-κB and NLRP3/Caspase-1/GSDMD Signaling Pathways
Wu et al. Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo
Meng et al. Qing-Re-Chu-shi decoction ameliorates 2, 4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice through anti-inflammation and immunoregulatory mechanisms
EP3417856A1 (fr) Formulations topiques cannabis-based extraits et destinés à être utilisés dans des affections cutanées
Peng et al. Anti-inflammatory and immunomodulatory effects of polysaccharide extracted from Wuguchong (maggot) on 2, 4-dinitrochlorobenzene-induced atopic dermatitis in mice
Jo et al. Ameliorative and synergic effects of derma-H, a new herbal formula, on allergic contact dermatitis
de Almeida-Junior et al. Anti-inflammatory and antinociceptive effects of kaempferide from the Brazilian green propolis
Zhu et al. Xiaoyin-anshen formula alleviates psoriasis complicated by sleep disturbances by regulating melatonin, antioxidant enzymes, and pro-inflammatory cytokines in mice

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20221221

FZDE Discontinued

Effective date: 20221221